In the News
Featured on Major Media Outlets
During the COVID-19 pandemic, Dr. Anita Kohli and Yessica Sachdeva were widely recognized for their expertise and contributions. They were interviewed by major media outlets including CNN, ABC, KOLD and Arizona Midday. Their work highlighted groundbreaking efforts in antibody therapy trials, treatments for COVID-19 patients, prophylaxis strategies, and Regeneron’s monoclonal antibody therapy, showcasing their dedication to advancing patient care and innovative treatment options.
Understanding Clinical Trials
Phase 1: The first step in testing new treatments, Phase 1 trials focus on safety. Researchers evaluate how a drug interacts with the body, determine the safest dosage, and identify any side effects.
Phase2: In this stage, researchers continue monitoring safety and start assessing how effective the treatment is for specific conditions. These trials involve more participants, providing valuable insights into the treatment’s potential.
Phase 3: With even larger participant groups, Phase 3 trials confirm the treatment’s efficacy and refine dosing strategies. The data collected here determines if the treatment is ready for approval and widespread use.